Valley National Advisers’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.25K | Sell |
123
-957
| -89% | -$52K | ﹤0.01% | 711 |
|
|
2026
Q1 | $67K | Buy |
1,080
+125
| +13% | +$10K | 0.01% | 372 |
|
|
2025
Q4 | $90K | Sell |
955
-116
| -11% | -$11.4K | 0.01% | 326 |
|
|
2025
Q3 | $103K | Sell |
1,071
-186
| -15% | -$19.3K | 0.02% | 294 |
|
|
2025
Q2 | $134K | Buy |
1,257
+260
| +26% | +$26.3K | 0.02% | 277 |
|
|
2025
Q1 | $100K | Buy |
997
+602
| +152% | +$60.6K | 0.02% | 294 |
|
|
2024
Q4 | $35K | Buy |
395
+286
| +262% | +$25.2K | 0.01% | 386 |
|
|
2024
Q3 | $9K | Sell |
109
-7,492
| -99% | -$591K | ﹤0.01% | 529 |
|
|
2024
Q2 | $585K | Buy |
7,601
+28
| +0.4% | +$2.05K | 0.09% | 150 |
|
|
2024
Q1 | $518K | Buy |
7,573
+47
| +0.6% | +$3.02K | 0.08% | 162 |
|
|
2023
Q4 | $435K | Buy |
7,526
+170
| +2% | +$9.07K | 0.07% | 172 |
|
|
2023
Q3 | $388K | Buy |
7,356
+85
| +1% | +$4.46K | 0.07% | 185 |
|
|
2023
Q2 | $394K | Buy |
7,271
+7,149
| +5,860% | +$373K | 0.07% | 192 |
|
|
2023
Q1 | $6K | Hold |
122
| – | – | ﹤0.01% | 661 |
|
|
2022
Q4 | $5K | Hold |
122
| – | – | ﹤0.01% | 663 |
|
|
2022
Q3 | $5K | Buy |
122
+23
| +23% | +$923 | ﹤0.01% | 670 |
|
|
2022
Q2 | $4K | Hold |
99
| – | – | ﹤0.01% | 683 |
|
|
2022
Q1 | $4K | Hold |
99
| – | – | ﹤0.01% | 707 |
|
|
2021
Q4 | $4K | Buy |
99
+26
| +36% | +$1.09K | ﹤0.01% | 703 |
|
|
2021
Q3 | $3K | Hold |
73
| – | – | ﹤0.01% | 717 |
|
|
2021
Q2 | $3K | Hold |
73
| – | – | ﹤0.01% | 728 |
|
|
2021
Q1 | $3K | Hold |
73
| – | – | ﹤0.01% | 683 |
|
|
2020
Q4 | $3K | Hold |
73
| – | – | ﹤0.01% | 652 |
|
|
2020
Q3 | $3K | Hold |
73
| – | – | ﹤0.01% | 615 |
|
|
2020
Q2 | $3K | Hold |
73
| – | – | ﹤0.01% | 607 |
|
|
2020
Q1 | $2K | Hold |
73
| – | – | ﹤0.01% | 629 |
|
|
2019
Q4 | $3K | Hold |
73
| – | – | ﹤0.01% | 646 |
|
|
2019
Q3 | $3K | Hold |
73
| – | – | ﹤0.01% | 627 |
|
|
2019
Q2 | $3K | Hold |
73
| – | – | ﹤0.01% | 594 |
|
|
2019
Q1 | $3K | Hold |
73
| – | – | ﹤0.01% | 597 |
|
|
2018
Q4 | $3K | Hold |
73
| – | – | ﹤0.01% | 579 |
|
|
2018
Q3 | $3K | Hold |
73
| – | – | ﹤0.01% | 552 |
|
|
2018
Q2 | $2K | Buy |
+73
| New | +$2.2K | ﹤0.01% | 549 |
|
Other funds holding BSX
Valley National Advisers's BSX Position: Q2 2026 in Review
Valley National Advisers reduced its Boston Scientific (BSX) stake by 89% in Q2 2026, selling an estimated $52K and leaving 123 shares worth $5.25K. The position accounts for ﹤0.01% of the portfolio, ranked #711.
Valley National Advisers first reported a position in BSX in Q2 2018 and has held it in 33 quarters since. The position peaked at $585K in Q2 2024. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Valley National Advisers held 123 shares of Boston Scientific worth $5.25K as of Q2 2026.
- Valley National Advisers sold 957 Boston Scientific shares in Q2 2026, an estimated $52K.
- Boston Scientific made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #711 holding.
- Valley National Advisers first reported a position in Boston Scientific in Q2 2018 and has held it in 33 quarters since.
- Valley National Advisers's Boston Scientific position peaked at $585K in Q2 2024.
- 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.